Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost Mounjaro side effects appear within the first day or two after an injection and ease within a few days to about two weeks for the majority of people. That pattern comes directly from the clinical trial programme and is echoed in the NHS guidance on tirzepatide: gastrointestinal effects are most noticeable at the start of treatment or after a dose increase, then tend to tail off as the body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine, so how long side effects last after each stage of your treatment is something a prescriber can help you think through before any dose change.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and recorded side-effect timing in detail. Nausea, diarrhoea and vomiting were most concentrated around dose increases (particularly the early ones) and the overall incidence fell as participants moved through the 72-week period. The SmPC on the Electronic Medicines Compendium (eMC) formalises this: adverse reactions are predominantly gastrointestinal and are described as mild to moderate in severity, mostly transient.
In plain terms: if you inject on a Monday, you are most likely to feel any nausea or digestive change by Tuesday or Wednesday, and if you want to understand how soon after your Mounjaro injection side effects tend to appear, the pattern the evidence points to is that two-week window. By the following weekend, most people find the effect has substantially eased. That two-week window is not a ceiling (some people settle faster, some take a little longer) but it is the pattern the evidence points to.
Timing also shifts when the dose increases. If you have been comfortable on 5mg and your prescriber moves you to 7.5mg, the adjustment clock effectively resets. That is worth knowing, because people sometimes assume they are past the difficult part only to find 7.5mg briefly reintroduces nausea they thought had gone. It passes, but understanding why side effects return with dose changes makes the experience easier to sit with.
Nausea is the effect most people ask about first. It tends to peak in the 24 to 48 hours after an injection and, for most people on the starting dose, resolves without intervention. Eating smaller meals, avoiding very fatty or rich food around injection day, and staying well-hydrated all help — what and when you eat around your injection can make a noticeable difference.
Constipation follows a slightly different curve. It can arrive more gradually and, for some people, persists across multiple dose levels rather than resolving within days. Adequate fluid intake and fibre matter here. Diarrhoea, by contrast, often appears and clears within a day or two.
Fatigue and mild headache are reported by some people, again usually in the days immediately after an injection. Injection-site reactions (a small area of redness or tenderness where you injected) typically clear within a couple of days. Rotating sites (abdomen, thigh, upper arm) across weeks helps reduce them.
If you keep your pen in the fridge door rather than buried at the back, it is easier to take it out 30 minutes before injecting, which many people find reduces local discomfort. The SmPC and Patient Information Leaflet hold the exact guidance on temperature windows.
A fuller picture of the whole side-effect profile is covered in the Mounjaro side effects overview on the nume site, including rarer effects that most people will never experience but should be aware of.
The distinction between an expected temporary effect and a warning sign matters, and this section is the one to read carefully.
Severe stomach pain that does not pass (particularly pain that radiates toward the back, with or without vomiting) should not be waited out. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines including tirzepatide, identifying acute pancreatitis as an infrequent but serious risk. The message from regulators and clinicians is the same: do not self-manage this symptom; seek medical help the same day.
Other situations where you should contact a doctor or 111 promptly: signs of a gallbladder problem (severe pain in the upper right abdomen, fever, yellowing of the skin or eyes); significant dehydration from prolonged vomiting or diarrhoea that you cannot control with fluids; signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing); and any sudden changes to vision. Low mood or thoughts of self-harm, while rare, are also listed on patient information sheets, they deserve a call to a clinician, not a wait.
If you are ever uncertain whether what you are experiencing is expected or not, our prescribers are available; the contact page has support details, and this page covers what to do if effects feel overwhelming.
The MHRA's Yellow Card scheme lets patients report suspected side effects directly, and doing so contributes to the post-market safety monitoring that keeps guidance like the January 2026 update current.
Nobody can predict with certainty whether, or for how long, a particular person will experience side effects. What a prescriber can do is look at your medical history, any existing conditions and current medicines and identify factors that might make GI effects more pronounced or that would rule out treatment altogether.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it is submitted. They are not processing a form, they are making a clinical judgement about whether Mounjaro is appropriate for you, at what starting point, and what to watch for. Side effects, what is expected and what is not, are part of that conversation. You can read more about the Mounjaro treatment itself on the Mounjaro overview page, and if you are weighing your options across treatments, the weight-loss treatments overview gives broader context.
If you are ready to discuss your own situation, including how your health history might affect your experience on treatment, you can start a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.